New Clinical Trials Data Bank

Publication
Article
OncologyONCOLOGY Vol 14 No 5
Volume 14
Issue 5

The National Library of Medicine has started posting information about clinical trials in its new Clinical Trials

The National Library of Medicine has started posting information about clinical trials in its new Clinical Trials Data Bank (http://clinicaltrials.gov). At present, the new bank contains more data than had formerly been available on the NIH clinical trials website, and it will be expanded throughout 2000 to include trials sponsored by other federal agencies and the private sector. The trials included in the new data bank are only those conducted under an FDA investigational new drug application for serious or life-threatening diseases, such as cancer or AIDS. In conjunction with establishment of the data bank, the FDA has published draft guidance on what kind of information clinical trial sponsors must submit (www.fda.gov/cder/guidance/index.htm).

Recent Videos
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
2 experts are featured in this series.
Advancements in antibody drug conjugates, bispecific therapies, and other targeted agents may hold promise in lung cancer management.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Thomas Marron, MD, PhD, presented a session on clinical data that established standards of care for stage II and III lung cancer treatment at CFS 2025.
Related Content